tag:blogger.com,1999:blog-3521283112084840754.post5102883575556069081..comments2023-08-31T05:29:42.241-07:00Comments on Student's View on Strategic Management: Porter's Five Forces Analysis for the Pharmaceutical IndustryMaria Gabriela Marinhttp://www.blogger.com/profile/12393521264865472287noreply@blogger.comBlogger9125tag:blogger.com,1999:blog-3521283112084840754.post-18355045307773399432013-08-20T10:27:10.775-07:002013-08-20T10:27:10.775-07:00Hi,
what is the bargaining power for pharmacist a...Hi,<br /><br />what is the bargaining power for pharmacist and inurances? (public or private)Anonymoushttps://www.blogger.com/profile/01663178219995164169noreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-5202985859014327862013-01-20T23:23:38.200-08:002013-01-20T23:23:38.200-08:00but affu there are some sites like "fierce b...but affu there are some sites like "fierce biotech" which says astrazeneca on an average spending 4.5 billion dollar in r&d for getting a new drug into the market..would u believe this....? dont rely on this sites ra affu..johnhttps://www.blogger.com/profile/13040187379033853427noreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-15967695331962032672013-01-20T23:09:04.066-08:002013-01-20T23:09:04.066-08:00my frend john r&d cost for one molecule to ent...my frend john r&d cost for one molecule to enter into the market is around $1 billion....affuhttps://www.blogger.com/profile/04095651187413289940noreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-51040068149473236522013-01-20T22:52:48.943-08:002013-01-20T22:52:48.943-08:00pattipaka janardhan
yes i agreee the entry barrie...pattipaka janardhan<br /><br />yes i agreee the entry barriers are high due to<br /> 1) high r&d costs involved in the drug development i,e more than 194 million dollar for each drug to take into market..<br /><br />2)srict regulatory conditions imposed on by the FDA in the drug approval process<br /><br />3)longer period of more than 15 years of the time taken for the introduction of the drug into market<br /><br />5)high fixed cost involved and the lack of intelectual property protection in some semi regulated and reregulated countries<br /><br />6) sales and marketing costs involved are also substantially increasing as companies need to spend huge amount of the money on sales force to move the product in the market<br /><br />7)cost of conducting the clinical trails also increasing substantially..<br /><br />6) fda withdrawl of drugs are also increasing substantially if the drug is to show adverse effects after releasing into the market (drug recall)<br /><br />7) the govt intervention in the pricing through policies like the new drug pricing policy in india..<br /><br />8) the apllication for the compulsory licensing by the company may increase which may effect the revenues of the innovator companies<br /><br />9)stricter regulatory control in drug application in the form of NDA and the manufaCturing in the form of GMP,regulation in advertising and promotional aspects in the form of the drug and magic remedies act..<br /><br /><br /><br />johnhttps://www.blogger.com/profile/13040187379033853427noreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-81681625186007120502012-04-13T08:10:40.009-07:002012-04-13T08:10:40.009-07:00Though its a good analysis, its very general. Phar...Though its a good analysis, its very general. Pharmaceutical industry has three major divisions and the 5forces vary in them. API, generic and patent drugs have different forces.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-53376406934802764672008-04-12T11:40:00.000-07:002008-04-12T11:40:00.000-07:00Thanks Diana for your comment on my analysis of th...Thanks Diana for your comment on my analysis of the Pharmaceutical Industry. <BR/><BR/>Although I agree that the profit margin for drugs is high, I still believe that the entry barriers are too high for new entrants for this industry in the US. <BR/><BR/>Perhaps, it may be easier for a well established foreign pharmaceutical company to expand its operations in the US rather than starting from scratch.Maria Gabriela Marinhttps://www.blogger.com/profile/12393521264865472287noreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-78222300456202121692008-03-30T11:50:00.000-07:002008-03-30T11:50:00.000-07:00Hi, Maria:I agree with your thorough analysis, how...Hi, Maria:<BR/>I agree with your thorough analysis, however, I think pharmaceurical is an attactive industry to enter. Just as you analyzed, the costs of some drugs are low and the profits are high. For example, a drug only costs few cents, but pharmacy sells it for more than $50. It could be a very profitable business if you develop a good business plan. Overall, I like your analysis.Diana Sunhttps://www.blogger.com/profile/15675920438418420952noreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-6370385883150686082008-03-29T10:15:00.000-07:002008-03-29T10:15:00.000-07:00I agree with your analysis of the pharmaceutical i...I agree with your analysis of the pharmaceutical industry. There are many factors that are unfavorable to this industry. The high entry barriers is already a big obstacle that stops most of the people who want to get into this industry. Moreover, I also think this industry is risky and need lots of efforts to survive.Shumei Lihttps://www.blogger.com/profile/14673629357874236699noreply@blogger.comtag:blogger.com,1999:blog-3521283112084840754.post-41931852576840998272008-03-27T15:21:00.000-07:002008-03-27T15:21:00.000-07:00After reading your post of the Pharmaceutical Indu...After reading your post of the Pharmaceutical Industry using the porter's analysis, I agree with you that the attractiveness of this industry is low, I think that the entry barrier of the high cost and time needed with R&D and government regulation is really the number one reason making this industry unattractive.Haiqun Luhttps://www.blogger.com/profile/04453494677289017907noreply@blogger.com